A transplant team at a Birmingham hospital has achieved a world first after resuscitating a liver that would have previously been considered unviable.
Over the next few years, the University Medical Center (UMC) Utrecht and Quirem Medical will be working closely together to maximize the benefits of using holmium microspheres to treat liver cancer patients worldwide.
In a series of studies involving 140 American men and women with liver tumors, researchers at Johns Hopkins have used specialized 3-D MRI scans to precisely measure living and dying tumor tissue to quickly show whether highly toxic chemotherapy – delivered directly through a tumor’s blood supply – is working.
Medicine is not immune to prejudices. In the past, the ‘fatty liver’ diagnosis was often accompanied by the hasty conclusion that the problem was surely caused by alcohol abuse.
Japanese scientists have cracked open a freaky new chapter in the sci-fi-meets-stem-cells era. A group in Yokohama reported it has grown a primitive liver in a petri dish using a person's skin cells.
The hepatocellular carcinoma is the sixth most frequent cause of cancer worldwide, explained Dr Bruno Sangro at ECR, and it is the third most frequent cause of death due to cancer.
Across the globe, up to 400 million people carry the hepatitis B virus, and more than 180 million – approximately 400,000 in France – are infected with the hepatitis C virus.
Simultaneous surgical successes open new perspectives for multiple transplants
A record number of liver transplants have been carried out by the Birmingham Liver Teams at Queen Elizabeth Hospital Birmingham and Birmingham Children’s Hospital.
CT-ultrasound fusion optimises planning and monitoring of ablations in interventional radiology.
For his Wilhelm Conrad Röntgen Honorary Lecture at ECR 2011, Professor Richard Baron MD, from the Radiology Department at the University of Chicago, USA, focused on Detecting liver tumours: the search for the Holy Grail. Why does he compare this aim with that of the medieval knights?
Devised by the European Liver Test group, the new, non-invasive Enhanced Liver Fibrosis (ELF) test on Siemens ADVIA Centaur Immunoassay Systems can identify, in under an hour, bloodbased biomarkers to detect the amount of fibrosis in the liver.
EH Paris correspondent Annick Chapoy, reports on a French study that confirms the relevance of a drug with a long history in the management of other diseases
A Birmingham hospital is pioneering a new procedure which aims to maintain and improve the quality of organs for transplantation in recipients on the waiting list.
People who donate a portion of their livers for transplant to a relative or friend whose liver is failing can generally expect to live long, healthy lives and recover safely from the donation surgery, Johns Hopkins researchers have found.
Susanne Werner reports on the views and revelations of international researchers gathered to deliberate the future potential of reprogrammed human adult stem cells and personalised medical treatments
The European Research Council (ERC) has earmarked about €2.5 mio. to fund the research being conducted by gastroenterologist and biochemist Professor Dr. Dr. Detlef Schuppan at Mainz University Medical Center. Professor Schuppan is a specialist in liver diseases ranging from fibrosis to cirrhosis (the terminal stage of fibrosis) to hepatic cancer.
A Birmingham hospital trust is expanding its kidney dialysis service by commissioning a tenth satellite unit – its first outside England. University Hospitals Birmingham NHS Foundation Trust is to provide a chronic haemodialysis facility at a hospital in Powys, mid-Wales.